Search
Search Results
-
Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future
In this narrative review, we aim to explore the ability of radiation therapy to eradicate breast cancer regional node metastasis. It is a journey...
-
Clip** a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?
BackgroundSentinel lymph node (SLN) biopsy for cN+ breast cancer patients after neoadjuvant chemotherapy (NAC) is controversial because the...
-
Use of LigaSure vessel sealing system versus conventional axillary dissection in breast cancer patients: a retrospective comparative study
BackgroundIn locally advanced breast cancer, axillary lymph node dissection remains a pivotal component of surgical therapy. Apart from this, it has...
-
To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?
BackgroundAxillary lymph node (ALN) involvement is important for prognosis and guidance of multidisciplinary treatment of breast cancer patients....
-
Interesting Presentation of Mycosis Fungoides in Staging on F-18 FDG PET/CT
Mycosis fungoides is the major form of primary cutaneous T cell lymphoma. Its staging is based on the percentage of body surface involvement and...
-
Does Neoadjuvant Chemotherapy in Clinical T1–T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?
BackgroundCurrent management strategies for early-stage triple-negative breast cancer (TNBC) include upfront surgery to determine pathologic stage to...
-
European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision
Axillary lymphadenopathy is a common side effect of COVID-19 vaccination, leading to increased imaging-detected asymptomatic and symptomatic...
-
Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
ObjectiveThis systematic review examined the diagnostic performance of magnetic resonance imaging (MRI) for assessing axillary lymph node status...
-
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
PurposeTo assess the diagnostic performance of Whole Body (WB)-MRI in comparison with 18F-Fluorodeoxyglucose-PET/CT (18F-FDG-PET/CT) in lymphoma...
-
Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis
BackgroundMale breast cancer (MBC) is rare, and management is extrapolated from trials that enroll only women. It is unclear whether contemporary...
-
Exploring the most appropriate lymph node staging system for node-positive breast cancer patients and constructing corresponding survival nomograms
BackgroundThe lymph node (LN) status is a crucial prognostic factor for breast cancer (BC) patients. Our study aimed to compare the predictive...
-
Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study
ObjectiveThe aim of this study was to assess the diffusion-weighted whole-body-MRI (WBMRI) in the initial staging of breast cancer at high risk of...
-
Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients
PurposeThe outcome of the sentinel lymph node in breast cancer patients affects adjuvant treatment. Compared to conventional histopathology, analysis...
-
Omitting axillary dissection: could we offer a more tailored management to elderly patients with breast cancer?
We retrospectively reviewed the data from patients ≥ 70 years old treated between January 2012 and January 2017. Axillary staging was scarcely used...
-
The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer
BackgroundInflammatory breast cancer (IBC) has historically been characterized by high rates of recurrence and poor survival; however, there have...
-
Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer
ObjectivesThis study aimed to determine whether post-neoadjuvant therapy (NAT) axillary ultrasound (AUS) could reduce the false-negative rate (FNR)...
-
Contemporary Axillary Management in cT1–2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database
BackgroundManagement of the axilla in patients with cT1–2N0 breast cancer with one or two positive (+) sentinel lymph nodes (SLNs) is often debated,...
-
Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: a single-centre experience in 285 women
PurposeTo assess the incidence of axillary lymphadenopathy over established time ranges after COVID-19 vaccination and lymph node pathologic features...
-
Extent of Axillary Dissection: How Far Down Should We Dissect?
Axillary lymph node dissection (ALND) is the ‘gold standard’ surgical procedure for the management of metastatic axillary nodes in patients with...
